HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 234.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 290.00p
  • 52 Week Low: 189.00p
  • Currency: UK Pounds
  • Shares Issued: 872.15m
  • Volume: 17,297
  • Market Cap: £2,040.83m
  • RiskGrade: 226
  • Beta: 1.50

Latest ShareCast News

Hutchmed takes wraps off expanding oncology pipeline

By Josh White

Date: Monday 03 Nov 2025

(Sharecast News) - Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its next-generation antibody-targeted therapy conjugate (ATTC) platform, during its annual research and development update on Monday.

HCM Regulatory News

Vesting of awards under Long Term Incentive Plan 21-Oct-2025 09:30 RNS
Appointment of Independent Non-executive Director 14-Oct-2025 09:30 RNS
Total Voting Rights 30-Sep-2025 09:30 RNS
Directorate Change 26-Aug-2025 07:00 RNS
2025 Interim Results 07-Aug-2025 12:00 RNS

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 234.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 290.00p
52 Week Low 189.00p
Volume 17,297
Shares Issued 872.15m
Market Cap £2,040.83m
Beta 1.50
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average43.68% below the market average
31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average31.71% below the sector average
Price Trend
21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average21.97% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Income Not Available
Growth
44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average44.06% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

HCM Dividends

No dividends found

Trades for 04-Nov-2025

Time Volume / Share Price
16:35 2,982 @ 234.00p
16:35 2,705 @ 234.00p
16:35 248 @ 234.00p
16:35 14 @ 234.00p
16:35 7 @ 234.00p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page